Table 3.

Primary and secondary endpoint rates according to high-sensitivity C-reactive protein (hs-CRP) quartiles in the overall study population and in patients with and without diabetes mellitus

	Hs-CRP quartiles
	1 (< 1.45 mg/L)	2 (1.45-3.71 mg/L)	3 (3.72-12.29 mg/L)	4 (> 12.30 mg/L)	P for trend
In-hospital clinical combined endpoint, n (%)
Overall population	35 (7%)	44 (9%)	68 (13%)	114 (22%)	< 0.0001
Patients with diabetes mellitus	14 (14%)	11 (9%)	29 (21%)	51 (27%)	0.0001
Patients without diabetes mellitus	21 (5%)	33 (8%)	39 (10%)	63 (19%)	< 0.0001
Two-year mortality, n (%)
Overall population	25 (5%)	36 (7%)	49 (9%)	88 (17%)	< 0.0001
Patients with diabetes mellitus	11 (11%)	18 (15%)	20 (15%)	41 (22%)	0.01
Patients without diabetes mellitus	15 (4%)	18 (5%)	29 (8%)	47 (14%)	<0.0001